The Atrial fibrillation market was valued at US$ 6,446.08 million in 2019 and is expected to grow at a CAGR of 14.0% from 2020 to 2027 to reach US$ 18,085.96 million by 2027. Atrial fibrillation also referred to as AFib or AF is a medical condition that causes irregular heartbeat (arrhythmia) and which can further lead to blood clots, stroke, heart failure and other heart-related complications.The global atrial fibrillation market is driven by factors such as include increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. However, high cost of atrial fibrillation devices and procedures is likely to have negative impact on the growth of the market in the coming years. For More Info @ https://www.theinsightpartners.com/reports/atrial-fibrillation-market